Publications by authors named "Magnus M Halldin"

Claim this Profile
T
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover study.
Adriana Miclescu, Rolf Karlsten, Ingrid Lönnstedt, Magnus M Halldin, Märta Segerdahl

Scand J Pain· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics.
Boel Nilsson, Johan Bylund, Magnus M Halldin, Matthias Rother, Erik Rein-Hedin

Eur J Clin Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction.
Märta Dahlström, Nather Madjid, Gunnar Nordvall, Magnus M Halldin, Erika Vazquez-Juarez

Cells· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet-C exposed skin in healthy volunteers.
Erik Sjögren, Lars Ståhle, Hans Quiding, Bror Jonzon, Magnus M Halldin

Eur J Pain· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Free Drug Concentration in Cyclodextrin Formulations Is Essential to Determine Drug Potency in Functional In Vitro Assays.
Erik Sjögren, Sara Andersson, Anna K Sundgren-Andersson, Magnus M Halldin, Olle Stålberg

J Pharm Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The battle of Alzheimer's Disease - the beginning of the future Unleashing the potential of academic discoveries.
Johan Lundkvist, Magnus M Halldin, Johan Sandin, Gunnar Nordvall, Pontus Forsell

Front Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic approaches to determine the exposures of drug metabolites in preclinical and clinical subjects in the MIST evaluation of the clinical development phase.
Johanna Haglund, Magnus M Halldin, Asa Brunnström, Göran Eklund, Antti Kautiainen

Chem Res Toxicol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis